Vartanian, Meghedi
Endres, Konrad Jakob
Lee, Yee Teng
Friedrich, Silke
Meemken, Marie-Theres
Schamarek, Imke
Rohde-Zimmermann, Kerstin
Schürfeld, Robin
Eisenberg, Lina
Hilbert, Anja
Beyer, Frauke
Stumvoll, Michael
Sacher, Julia
Villringer, Arno
Christensen, Julia F.
Witte, A. Veronica
Funding for this research was provided by:
The Friedrich-Naumann-Foundation for Freedom (9294 / P30203)
Deutsche Forschungsgemeinschaft, DFG (493646873 – MD-LEICS, 464596826, 209933838, CRC 1052/3, Project A1, 209933838, CRC 1052/3, Project A1)
Max Planck Institute for Human Cognitive and Brain Sciences
Article History
Received: 12 April 2024
Accepted: 4 December 2024
First Online: 13 January 2025
Declarations
:
: This study was approved by the ethics committee of research, at the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany in March 2021. There are three amendments dated February, April, and December 2022 and including the neurocognitive behavioral arm, new consent forms, and second blood draw. Each participant receives written informed consent outlining their complete voluntary participation in the study and their right to withdraw at any time, for any reason.
: Not applicable.
: The authors declare no competing interests.